What happens when you take carbamazepine with st. john's wort?
Carbamazepine (brand names Tegretol, Carbatrol, Equetro, and others) is a widely used anticonvulsant that also treats trigeminal neuralgia and acts as a mood stabilizer in bipolar disorder. It is cleared mainly by the liver enzyme CYP3A4, and it has the unusual property of speeding up its own breakdown over the first few weeks of treatment — a process called autoinduction. St. John's Wort is itself a potent inducer of CYP3A4. When the two overlap, here is what unfolds:
- Both pull the same enzymatic lever. St. John's Wort activates the pregnane X receptor, ramping up CYP3A4 — the same pathway carbamazepine is already pushing on through autoinduction.
- The effect is uneven, not dramatic. In people already at a steady carbamazepine level, adding St. John's Wort did not meaningfully lower carbamazepine further, because the drug had already maximally induced its own clearance. Before that self-induction is established, the herb appears to lower carbamazepine exposure modestly.
- Transitions are where the risk concentrates. Starting carbamazepine, restarting after a break, or stopping St. John's Wort can each shift the balance. The most consequential moment is stopping the herb while staying on carbamazepine.
- Withdrawal of the herb lets levels drift upward. As St. John's Wort's enzyme induction fades over a week or two, carbamazepine clearance falls and blood levels can climb — sometimes enough to cause symptoms.
The practical takeaway is unpredictability. The size of any change depends on the herbal product's hyperforin content, individual genetics, where someone is in the autoinduction process, and other medications.
Why is this important?
Carbamazepine has a relatively narrow therapeutic window. Too little, and people risk breakthrough seizures, mood instability, or the return of trigeminal neuralgia pain. Too much, and they can develop dizziness, double or blurred vision, unsteadiness (ataxia), drowsiness, and low sodium (hyponatremia); rare but serious effects include bone-marrow suppression and severe skin reactions such as Stevens-Johnson syndrome, which is more likely in carriers of the HLA-B*1502 gene variant.
The riskiest scenario is stopping St. John's Wort while continuing carbamazepine. As the induction wears off, carbamazepine levels can rise and a previously stable person can tip toward toxicity. In the other direction, starting the herb in someone not yet fully autoinduced can lower carbamazepine exposure enough to threaten seizure or mood control.
Regulators reinforce caution here. The UK's MHRA advises avoiding St. John's Wort with antiepileptic drugs, including carbamazepine, because enzyme induction can lead to loss of seizure control. Other agencies carry similar warnings.
There is also an overlap-of-populations problem. St. John's Wort is taken mainly for low mood, and people with epilepsy or bipolar disorder have higher-than-average rates of depression. That makes the at-risk group for this combination larger than it might first appear.
What should you do?
If you take carbamazepine for any reason, the simplest safe choice is to not start St. John's Wort. The unpredictability of the interaction makes safe co-use impractical. If you are already taking both, do not stop the herb on your own — plan the change with your prescriber. Here is a sensible sequence:
- Before any change: Tell your prescriber or pharmacist you are taking both. Ask whether a baseline carbamazepine blood level makes sense before you stop the herb, and agree on a monitoring plan.
- Every day during the transition: Watch for early signs that your carbamazepine level may be climbing — new dizziness, blurred or double vision, unsteadiness, or unusual drowsiness. Keep taking your carbamazepine exactly as prescribed; do not adjust the dose yourself.
- After stopping the herb: Follow up with your prescriber for a repeat carbamazepine level once the herb's enzyme effect has worn off (typically a week or two later), and let them decide whether a dose adjustment is needed.
If your reason for considering St. John's Wort was depression, raise that directly with your prescriber. There are evidence-based options that can be used alongside carbamazepine, though carbamazepine's enzyme induction can lower the exposure of some antidepressants, so the choice and dosing should be supervised. Talking therapy and lifestyle measures are also reasonable first steps.
One more thing: carbamazepine already reduces the reliability of hormonal contraceptives through the same CYP3A4 pathway, and St. John's Wort can compound that. Anyone on carbamazepine who could become pregnant should discuss a contraceptive method that does not depend on hormones vulnerable to enzyme induction.
Which specific products are affected?
On the medication side, this applies to all formulations of carbamazepine, including:
- Tegretol (immediate-release tablets and suspension)
- Tegretol XR (extended-release)
- Carbatrol and Equetro (extended-release capsules)
- Generic carbamazepine immediate- and extended-release products
The related drug oxcarbazepine (Trileptal) is handled largely by different enzymes, so the St. John's Wort interaction is less well characterized — but caution is still reasonable.
On the supplement side, the concern covers essentially all hyperforin-containing St. John's Wort products:
- Standardized Hypericum perforatum capsules and tablets
- St. John's Wort teas and tinctures
- Combination herbal "mood" or "calm" blends that include St. John's Wort
The science behind it
A small human pharmacokinetic study by Burstein and colleagues gave St. John's Wort to eight healthy volunteers already at steady-state carbamazepine and found no further reduction in carbamazepine levels — consistent with the idea that carbamazepine had already maximally autoinduced its own metabolism (Burstein AH, et al., Clin Pharmacol Ther, 2000; PMID 11180020). A later review by Chrubasik-Hausmann and colleagues examined how St. John's Wort's hyperforin content drives its interaction potential, describing a modest reduction in single-dose carbamazepine exposure before autoinduction is established (J Pharm Pharmacol, 2019).
On the regulatory side, the UK MHRA's Drug Safety Update advises avoiding St. John's Wort with antiepileptic drugs because of enzyme induction and the risk of losing seizure control. The clinical concern rests less on a large average drop in levels and more on the narrow therapeutic window and the level swings that occur when the herb is started or stopped.
Frequently Asked Questions
Can I take St. John's Wort if my carbamazepine level has been stable for years?
It is still not advised. Even if steady-state levels are not greatly lowered, later stopping the herb can let your carbamazepine level rise, and starting it adds avoidable uncertainty to a drug with a narrow safety margin. Talk to your prescriber first.
Why is stopping St. John's Wort described as the dangerous part?
While you take the herb, its enzyme-inducing effect is part of your baseline. When you stop, that induction fades over a week or two, your carbamazepine is cleared more slowly, and levels can climb toward the toxic range if nothing else changes.
What symptoms should make me call my prescriber?
New or worsening dizziness, double or blurred vision, unsteadiness on your feet, or unusual drowsiness can signal that your carbamazepine level is too high. Breakthrough seizures or a clear return of mood symptoms or nerve pain can signal levels that are too low.
Is the interaction the same with oxcarbazepine (Trileptal)?
Oxcarbazepine is processed mostly by different enzymes, so the interaction is less well studied and likely smaller. Caution is still reasonable — check with your pharmacist.
I'm taking St. John's Wort for low mood. What are my options on carbamazepine?
Ask your prescriber about evidence-based antidepressants that can be used with carbamazepine (dosing may need adjustment because of enzyme induction), as well as talking therapy and lifestyle measures. Self-treating with the herb adds more interaction risk than most prescription options.
Does this affect my birth control?
It can. Carbamazepine already weakens hormonal contraceptives through CYP3A4, and St. John's Wort can add to that. If you could become pregnant, discuss a method that does not rely on enzyme-vulnerable hormones.
Key takeaways
- Both carbamazepine and St. John's Wort induce CYP3A4; the combined effect is unpredictable rather than uniformly large.
- The biggest risk is at transitions — especially stopping the herb while on carbamazepine, which can let drug levels rise toward toxicity.
- Carbamazepine's narrow therapeutic window means small shifts in either direction can matter.
- Do not start St. John's Wort on carbamazepine; if you already take both, change it only under medical supervision with level monitoring.
- For depression, ask your prescriber about safer, evidence-based alternatives, and review any change with your doctor or pharmacist.